Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced a planned reverse stock split of ...
Bone Biologics (NASDAQ:BBLG) said it intends to conduct a 1-for-8 reverse stock split before market open on Wednesday, Dec. 20. The split-adjusted shares will begin trading the same day. Following the ...
BURLINGTON, Mass.--(BUSINESS WIRE)-- Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces that a 1-for-30 reverse stock split became ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback